Article citationsMore>>

Korani, M., Fallah, S., Tehranian, A., Nourbakhsh, M., Samadikuchaksaraei, A., Pour, M.S. and Maleki, J. (2013) The Evaluation of FOXO1, KLF9 and YT521 Genes Expression in Human Endometrial Cancer. Clinical Laboratory, 59, 483-489.

has been cited by the following article:

• TITLE: Evaluating the p-FOXO1/FOXO1 Ratio: An Alternative Strategy for Endometrial Cancer Diagnosis

  AUTHORS: Mohsen Korani, Soudabeh Fallah

  KEYWORDS: Endometrial Cancer, FOXO1, p-FOXO1, Transcription Factor

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.6 No.3, March 26, 2015

  ABSTRACT: Background: The FOXO subfamily of Forkhead transcription factors plays a central role in pro-moting expression of proapoptotic and cell cycle regulatory genes. FOXO1 expression has an im-portant role in human endometrium homeostasis. Therefore, reduced FOXO1 protein and its inactivation by phosphorylation might, play a role in progression of human endometrial cancer. Methods: Current study was designed to investigate the changes of the FOXO1, phosphorylated-FOXO1 (p-FOX1) proteins levels and the p-FOXO1/FOXO1 ratio in 30 patients with endometrial cancer and 20 subjects with normal endometrium, surgically using excised human endometrial tissue specimens, quantitative real time PCR and western blot methods. Results: FOXO1 protein level in patients with endometrial cancer significantly reduced in comparison with control group (0.17 ± 0.15 vs. 1 ± 0.14; p